Published in Clin Exp Allergy on June 01, 2006
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol (2010) 0.94
Block copolymer/DNA vaccination induces a strong allergen-specific local response in a mouse model of house dust mite asthma. PLoS One (2014) 0.82
The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice. Clin Exp Allergy (2014) 0.82
Iraq dust is respirable, sharp, and metal-laden and induces lung inflammation with fibrosis in mice via IL-2 upregulation and depletion of regulatory T cells. J Occup Environ Med (2014) 0.81
The effect of rush immunotherapy with house dust mite in the production of IL-5 and IFN-gamma from the peripheral blood T cells of asthmatic children. J Korean Med Sci (2009) 0.77
Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy. Clin Mol Allergy (2015) 0.75
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother (1980) 9.02
Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother (1979) 5.88
Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother (1983) 5.52
Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J Antibiot (Tokyo) (1979) 4.82
Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother (1977) 4.14
Twenty five year mortality and air pollution: results from the French PAARC survey. Occup Environ Med (2005) 3.07
Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. J Antimicrob Chemother (1978) 2.75
Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol (1997) 2.48
Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol (1992) 2.14
Can mite-specific IgE be used as a surrogate for mite exposure? Allergy (1994) 2.02
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Am J Med (1985) 1.90
Drugs that may injure the respiratory system. Eur Respir J (1997) 1.86
Prevalence of latex allergy in operating room nurses. J Allergy Clin Immunol (1992) 1.76
Importance of inhaler devices in the management of airway disease. Respir Med (2007) 1.76
A single dose of melatonin prevents the phase delay associated with a delayed weekend sleep pattern. Sleep (2001) 1.75
Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75
Evaluation of a portable clinical blood analyzer in the emergency department. Acad Emerg Med (1995) 1.62
Lineages, quantal cell cycles, and the generation of cell diversity. Q Rev Biophys (1975) 1.59
Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med (2000) 1.59
The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med (2006) 1.54
Latex as aeroallergen. Lancet (1990) 1.51
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J (1998) 1.51
Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: I--Immunological assessment. Clin Exp Allergy (1994) 1.45
Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis (1989) 1.43
Knowledge and beliefs of samples of the general population about asthma. Chest (2000) 1.43
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. Dermatology (2003) 1.40
Cockroaches and mites share the same beds. J Allergy Clin Immunol (1995) 1.39
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science (1985) 1.39
[AIDS: a model for the study of atopy?]. Rev Mal Respir (1995) 1.39
Standardization of house-dust sampling. Allergy (1994) 1.39
Inhibition of a pacemaker during nerve stimulation for regional anaesthesia. Anaesthesia (2007) 1.38
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy (2005) 1.35
Fire-eater's lung: seventeen cases and a review of the literature. Medicine (Baltimore) (2001) 1.34
Betaine-homocysteine transmethylase in Pseudomonas denitrificans, a vitamin B 12 overproducer. J Bacteriol (1973) 1.29
Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur Respir J (1999) 1.25
EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-- descriptive characteristics. Clin Exp Allergy (1999) 1.23
Altitude and allergy to house-dust mites. A paradigm of the influence of environmental exposure on allergic sensitization. Am Rev Respir Dis (1991) 1.22
Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol (1983) 1.22
Alteration of permeability for the release of metabolites from the microbial cell. Curr Top Microbiol Immunol (1968) 1.22
Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med (1997) 1.21
Substance use and its relationship to depression, anxiety, and isolation among youth living with HIV. Int J Behav Med (1999) 1.19
Biosynthesis of biotin in microorganisms. V. Control of vitamer production. J Bacteriol (1967) 1.17
Allergic vs nonallergic asthma: what makes the difference? Allergy (2002) 1.14
Biosynthesis of fosfomycin by Streptomyces fradiae. Antimicrob Agents Chemother (1974) 1.13
Epithienamycins. II. Isolation and structure assignment. J Antibiot (Tokyo) (1981) 1.13
[Hypersensitivity to carboplatin. An effect of generic drugs?]. Rev Mal Respir (2006) 1.09
Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis (1984) 1.09
A prospective national study of the safety of immunotherapy. Clin Allergy (1980) 1.08
Haemoptysis after breath-hold diving. Eur Respir J (1999) 1.08
Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheumatol (2014) 1.08
EAACI position statement on asthma exacerbations and severe asthma. Allergy (2013) 1.07
[Factors associated with smoking in sixth grade (11-13 years old)]. Rev Mal Respir (2002) 1.07
[Oleanolic acid, anaerobe growth factor of wine yeast]. C R Acad Sci Hebd Seances Acad Sci D (1971) 1.06
[Demonstration of the mutagenic action of sodium sulfite on yeast]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.06
Product inhibition of the fermentative formation of glutamic acid. Appl Microbiol (1970) 1.06
Prevalence of asthma and rhinitis in relation to long-term exposure to gaseous air pollutants. Allergy (2000) 1.06
Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy (1999) 1.06
Asthma and allergy to house-dust mites in populations living in high altitudes. Chest (1988) 1.05
Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group. Am J Respir Crit Care Med (1996) 1.04
Reversal by citrate of the iodoacetate and fluoride inhibition of glutamic acid production by Corynebacterium glutamicum. Appl Microbiol (1969) 1.03
Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix. Urol Res (1995) 1.02
Value of ELISA using A60 antigen in the diagnosis of active pulmonary tuberculosis. Am Rev Respir Dis (1990) 1.02
Occupational asthma in France: a 1-yr report of the observatoire National de Asthmes Professionnels project. Eur Respir J (2002) 1.02
Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly. Digestion (1991) 1.00
Early T-cell development in CD3-deficient mice. Immunol Rev (1995) 0.98
17q21 variants modify the association between early respiratory infections and asthma. Eur Respir J (2009) 0.98
Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin Exp Allergy (2004) 0.97
Atopy and systemic reactions to hymenoptera stings. Allergy Proc (1994) 0.97
Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation (1996) 0.97
Altitude and house dust mites. J Allergy Clin Immunol (1982) 0.97
Gaseous air pollution and atopy. Clin Exp Allergy (1999) 0.97
T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy (2008) 0.97
Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy (2012) 0.96
Metabolism of biotin and analogues of biotin by microorganisms. II. Further studies on the conversion of D-biotin to biotin vitamers by Lactobacillus plantarum. J Bacteriol (1966) 0.96
Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy (1998) 0.95
Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab (1992) 0.95
Allergic emergencies seen in surgical suites. Clin Rev Allergy Immunol (1999) 0.95
[Is there an urban factor in asthma and allergy?]. Rev Mal Respir (1988) 0.95
Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy (1993) 0.95
Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy (2003) 0.94
T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy (2003) 0.94
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy (2009) 0.94
Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure. Allergy (2003) 0.93
Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation (1983) 0.93
Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol (1987) 0.93
Clinical studies with terfenadine in seasonal allergic rhinitis in France. Arzneimittelforschung (1982) 0.93